Results 1 to 10 of about 58,933 (213)

Over-the-counter access to combined oral contraceptives for individuals with hypertension: an expert review [PDF]

open access: yesAmerican Journal of Preventive Cardiology
Efforts are underway to move a combined oral contraceptive over the counter in the United States. However, hypertension is an important contraindication and questions exist regarding how users should screen for it in an over-the-counter setting.
Kate Grindlay   +6 more
doaj   +2 more sources

Thrombin generation in a woman with heterozygous factor V Leiden and combined oral contraceptives: A case report [PDF]

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2020
Combined oral contraceptives and factor V Leiden mutation are multiplicative risk factors for venous thromboembolism. However, it remains unknown whether this multiplicative effect is reflected in thrombin generation assays.
Maxime G. Zermatten   +3 more
doaj   +2 more sources

The effect of lavender on mood disorders associated with the use of combined oral contraceptives (COCs): a triple-blinded randomized controlled trial [PDF]

open access: yesBMC Complementary Medicine and Therapies
Background The use of contraceptive methods is influenced by their effectiveness, availability, and minimal side effects. OCPs are one of the most effective and widely used methods of pregnancy prevention worldwide.
Mina Naghdi   +4 more
doaj   +2 more sources

Investigating cardiovascular risk in premenopausal women on oral contraceptives: Systematic review with meta-analysis

open access: yesFrontiers in Cardiovascular Medicine, 2023
BackgroundThe use of oral contraceptives (OCs) is associated with an increased risk of cardiovascular events such as arterial and venous thrombosis (VTE).
Oyesanmi A. Fabunmi   +3 more
doaj   +1 more source

Estimate of venous thromboembolism and related-deaths attributable to the use of combined oral contraceptives in France. [PDF]

open access: yesPLoS ONE, 2014
PURPOSE: To estimate the number of venous thromboembolic events and related-premature mortality (including immediate in-hospital lethality) attributable to the use of combined oral contraceptives in women aged 15 to 49 years-old between 2000 and 2011 in ...
Aurore Tricotel   +3 more
doaj   +1 more source

Reproductive behavior of medical students: realities of contraceptive choice [PDF]

open access: yesГинекология, 2018
Representations of the society about the use of hormonal drugs for protection from unwanted pregnancy have the features of a deeply rooted behavioral and social stigmatization.
T A Oboskalova, O V Prohorova
doaj   +1 more source

Thromboembolic safety of norethisterone vs levonorgestrel in combined oral contraceptive users: a pooled analysis of 4 large prospective cohort studiesAJOG Global Reports at a Glance

open access: yesAJOG Global Reports, 2022
BACKGROUND: Norethisterone (acetate) and levonorgestrel are marketed globally as components of combined oral contraceptives. Although guidelines recommend both as first-line combined oral contraceptives, no direct, comparative safety studies are ...
Clare Barnett, MBBS (Hons), MPH   +3 more
doaj   +1 more source

Selected effects of combined oral contraceptives use

open access: yesJournal of Education, Health and Sport, 2022
Introduction and objective:: Combined oral contraceptives (COCs) are one of the most popular methods of contraception worldwide. The universality of this method leads to the constant analysis of its influence on the female body.
Julia Bogucka   +5 more
doaj   +1 more source

Topical issues in combined oral contraceptives usage [PDF]

open access: yesГинекология, 2018
The article presents topical issues of combined oral contraceptive (COC) use: among women with obesity, the effectiveness of COC in the management of premenstrual syndrome, the risk of thrombosis among women using of COCs and the economic justification ...
S O Dubrovina
doaj   +1 more source

Oral contraceptives combined with interferon β in multiple sclerosis [PDF]

open access: yes, 2015
Objective: To test the effect of oral contraceptives (OCs) in combination with interferon b (IFN-b) on disease activity in patients with relapsing-remitting multiple sclerosis (RRMS).
Barletta, Valeria T.   +10 more
core   +3 more sources

Home - About - Disclaimer - Privacy